Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Furmonertinib 160mg vs 80mg + Chemotherapy in EGFR-Mutated NSCLC With Brain Metastases: Efficacy and Safety Study

Tianjin Medical University Cancer Institute and Hospital · 2026
ClinicalTrials.gov · Datasets · License: Public Domain · 2026
Open Source ↗
non-small cell lung cancer (nsclc), brain metastases, furmonertinib, egfr mutation, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 1029985
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.